Routine Postoperative Antibiotics After Tissue Expander Placement Postmastectomy Does Not Improve Outcome.
Journal
Annals of plastic surgery
ISSN: 1536-3708
Titre abrégé: Ann Plast Surg
Pays: United States
ID NLM: 7805336
Informations de publication
Date de publication:
01 07 2021
01 07 2021
Historique:
pubmed:
10
4
2021
medline:
13
8
2021
entrez:
9
4
2021
Statut:
ppublish
Résumé
In an attempt to reduce the incidence of infectious complications after tissue expander-based breast reconstruction, the routine administration of postoperative antibiotics regimen is common in many practices. In recent years, there has been a plethora of reports scrutinizing the prophylactic use of postoperative antibiotics in this setting. The aim of this study was to determine the efficacy of prolonged administration of postoperative antibiotics compared with perioperative-only antibiotic administration for prophylaxis after tissue expander placement for immediate mastectomy reconstruction. A retrospective chart review of all patients who underwent immediate tissue expander placement after mastectomy at our institution from June 2005 to September 2018 was performed. All patients in the study received perioperative intravenous antibiotics 30 to 60 min preoperatively and for 24 hours postoperatively. Patients were divided into 2 groups. Patients in group A did not receive antibiotics beyond the perioperative period. Patients in group B received oral antibiotics for at least 7 days postoperatively in addition to the perioperative intravenous antibiotics. The 2 groups were compared for demographics and prevalence of risk factors such as radiation, chemotherapy, smoking, and diabetes. The incidence of complications such as infection, wound complications, hematoma, seroma, capsular contracture, loss of tissue expander, and reoperations was assessed. A total of 529 patients were included in the study, of which 241 were in group A and 288 were in group B. The total number of breasts reconstructed in group A was 398, whereas in group B, it was 466 breasts. Patients were followed up to 5 months postoperatively in each group. There were no statistically significant differences in the demographic and patient characteristics among the 2 groups. The incidence of infection in group A was 23.24% and in group B was 21.53% (P = 0.412). The incidence of other complications follows the same trend when comparing group A versus B. This retrospective study shows that the routine use of postoperative antibiotics after tissue expander placement for immediate mastectomy reconstruction does not result in reduction in the incidence of common complications or improvement of clinical outcomes.
Identifiants
pubmed: 33833164
doi: 10.1097/SAP.0000000000002826
pii: 00000637-202107001-00007
doi:
Substances chimiques
Anti-Bacterial Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
S28-S30Informations de copyright
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
Conflicts of interest and sources of funding: none declared.
Références
American Society of Plastic Surgeons. 2018 Plastic Surgery Statistics Report. 2019. Available at: https://www.plasticsurgery.org/news/plastic-surgery-statistics . Accessed September 15, 2020.
Bertozzi N, Pesce M, Santi P, et al. Tissue expansion for breast reconstruction: methods and techniques. Ann Med Surg (Lond) . 2017;21:34–44.
Alderman AK, Wilkins EG, Kim HM, et al. Complications in postmastectomy breast reconstruction: two-year results of the Michigan Breast Reconstruction Outcome Study. Plast Reconstr Surg . 2002;109:2265–2274.
Phillips BT, Halvorson EG. Antibiotic prophylaxis following implant-based breast reconstruction: what is the evidence? Plast Reconstr Surg . 2016;138:751–757.
Phillips BT, Bishawi M, Dagum AB, et al. A systematic review of antibiotic use and infection in breast reconstruction: what is the evidence? Plast Reconstr Surg . 2013;131:1–13.
Phillips BT, Wang ED, Mirrer J, et al. Current practice among plastic surgeons of antibiotic prophylaxis and closed-suction drains in breast reconstruction: experience, evidence, and implications for postoperative care. Ann Plast Surg . 2011;66:460.
Monroig K, Ghosh K, Marquez JE, et al. Do postoperative prophylactic antibiotics reduce highly virulent infections? Ann Plast Surg . 2020;85:S50–S53.
Bratzler DW, Houck PM. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Am J Surg . 2005;189:395–404.
Phillips BT, Fourman MS, Bishawi M, et al. Are prophylactic postoperative antibiotics necessary for immediate breast reconstruction? Results of a prospective randomized clinical trial. J Am Coll Surg . 2016;222:1116–1124.
McCullough MC, Chu CK, Duggal CS, et al. Antibiotic prophylaxis and resistance in surgical site infection after immediate tissue expander reconstruction of the breast. Ann Plast Surg . 2016;77:501–505.
Ranganathan K, Zhong L, Momoh AO, et al. Antibiotic prophylaxis after immediate breast reconstruction: the reality of its efficacy. Plast Reconstr Surg . 2017;141:865–877.
Amland PF, Andenaes K, Samdal F, et al. A prospective, double-blind, placebo-controlled trial of a single dose of azithromycin on postoperative wound infections in plastic surgery. Plast Reconstr Surg . 1995;96:1378–1383.
Wang F, Chin R, Piper M, et al. Do prolonged prophylactic antibiotics reduce the incidence of surgical-site infections in immediate prosthetic breast reconstruction? Plast Reconstr Surg . 2016;138:1141–1149.
Avraham T, Karp NS, Wilson S, et al. Postoperative expansion is not a primary cause of infection in immediate breast reconstruction with tissue expanders. Breast J . 2015 Jul;21:501–507.
Phillips BT, Bishawi M, Dagum AB, et al. A systematic review of infection rates and associated antibiotic duration in acellular dermal matrix breast reconstruction. Eplasty . 2014.
Avashia YJ, Mohan R, Berhane C, et al. Postoperative antibiotic prophylaxis for implant-based breast reconstruction with acellular dermal matrix. Plast Reconstr Surg . 2013;131:453–461.
Townley WA, Baluch N, Bagher S, et al. A single pre-operative antibiotic dose is as effective as continued antibiotic prophylaxis in implant-based breast reconstruction: a matched cohort study. J Plast Reconstr Aesthet Surg . 2015;68:673–678.
Clayton JL, Bazakas A, Lee CN, et al. Once is not enough: withholding postoperative prophylactic antibiotics in prosthetic breast reconstruction is associated with an increased risk of infection. Plast Reconstr Surg . 2012;130:495–502.